Attovia Therapeutics files for IPO on Nasdaq

Attovia Therapeutics filed for an initial public offering and applied to list its shares on the Nasdaq Global Market under the ticker “ATTO.” The clinical-stage biopharmaceutical company develops next‑generation biologi…

Read more →